Back to Home

Directions in Oncology Pharmacy® 2024: Northeast

Saturday, November 9, 2024

Countdown to Event

00

Days

00

Hours

00

Mins

00

Secs

Stream Link: https://event.arraylive.com/app/login/03bf5216-25d1-4f39-9613-a2ee4b8c0246

 

Overview

This full-day educational meeting will provide live practical education to pharmacists practicing in oncology in multiple practice environments including health-system, specialty pharmacy, outpatient clinic, and infusion center settings. Sessions will focus on evolving treatment strategies, including use of checkpoint inhibitors, antibody drug conjugates, and targeted oral and infusional therapies for the care of patients with solid tumors and hematologic malignancies.

Rapidly evolving use of immunotherapies and targeted therapies has changed the landscape for anticancer treatment. The complexity of new regimens and the need for coordination of care across practice and pharmacy settings has reinforced and expanded the roles of pharmacists both clinically and operationally. It is essential for pharmacists across settings to understand the different treatment options and dosing regimens, implement methods to improve patient adherence, educate other health care team members, and counsel patients during onboarding and ongoing treatment to manage potential adverse effects associated with these agents to optimize patient care and outcomes. This full-day educational meeting will provide live practical education to pharmacists in multiple practice settings who take care of patients with cancer. Didactic sessions will focus on evolving treatment strategies, including use of checkpoint inhibitors, antibody drug conjugates, and targeted oral and infusional therapies for the care of patients with solid tumors and hematologic malignancies. In addition, panel discussions will highlight key concepts for application in patient case scenarios.

Learning Objectives

Upon completion of this educational conference, pharmacists will be able to:

  • Identify strategies to foster the adoption of AI and health advancements within the practice of pharmacy to improve patient care
  • Examine the burden of chronic diseases and the evolving landscape of their management, including a review of efficacy and safety of new and emerging therapies
  • Analyze current guidelines for management of chronic diseases and updated vaccination recommendations
  • Identify the role of pharmacists in educating the health care team and patients, managing adverse effects, improving patient adherence, and coordinating care to improve patient outcomes

Moderator

Joseph A. Kalis, PharmD, BCOP

To view full profile, click on the Moderator tab above.